ZyVersa Therapeutics CEO Stephen Glover's 2023 pay falls 33% to $993K
ZyVersa Therapeutics reports 2023 executive compensation
By ExecPay News
Published: September 9, 2024
ZyVersa Therapeutics reported fiscal year 2023 executive compensation information on September 9, 2024.
In 2023, three executives at ZyVersa Therapeutics received on average a compensation package of $684K, a 22% decrease compared to previous year.
Average pay of disclosed executives at ZyVersa Therapeutics
Stephen C. Glover, Chief Executive Officer, received $993K in total, which decreased by 33% compared to 2022. 55% of Glover's compensation, or $550K, was in salary. Glover also received $225K in bonus and $218K in option awards.
Peter Wolfe, Chief Financial Officer, received a compensation package of $573K, which increased by 3% compared to previous year. 69% of the compensation package, or $395K, was in salary.
Karen A. Cashmere, Chief Commercial Officer, earned $487K in 2023, a 16% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 9, 2024.